In perioada analizata au fost supuse tratamentului antiluetic in conformitate cu noile scheme ale M. S. (Ord. 544/martie, 1995) un numar de 163 cazuri cu diferite forme de lues recent. Din analiza cazurilor reiese ca barbatii se inscriu cu un procentaj superior femeilor (55,2% fata de 44,8%); mediul urban domina ruralul (79% fata de 21%) iar persoanele fara ocupatie si somerii sunt in fruntea celor imbolnaviti (75%). Grupa de varsta cea mai afectata este 15-30 ani, cu o tendinta de scadere a limitei de varsta in aparitia bolii.

Ca forme clinice, sifilisul primar se inscrie cu 46,6% din cazuri iar sifilisul secundar si latent recent cu 53,4%.

Cazurile au fost supuse la terapia cu Penicilina cristalina, Efitard si Moldamin. tratamentul cu Penicilina cristalina a fost efectuat la 59 de bolnavi (36,3%), cu negativarea reactiilor serologice dupa 3-14 luni.

In concluzie, aplicarea acestor scheme de tratament a dat rezultate favorabile in 98% din cazurile urmarite. Nu am semnalat diferente in evolutia bolii in functie de forma de penicilina utilizata. Administrarea Moldaminului pare sa fie metoda cea mai comoda si eficienta, acceptata de bolnavi.

In the above mentioned period a number of 163 cases with different forms of recent syphilis were the subject of the treatment against syphilis, according to new scheme of M. S. (The M. S. Order 544/March, 1995).

After the analyses of these cases it has been established that the number of men that suffers of this illness is superior to that of women (55,2% and 44,8%); the urban population is more affected than the rural one (79% comparing 21%), and the people that have not job own the top places between the sick people (75%). The most affected people are between 15 and 30 years old (53,9%) and there is a tendency of reducing the limit of age.

As clinical forms of syphilis, the primary syphilis represents 46,6% of the cases while the secondary and recent syphilis that has not manifested yet represent 53,4%.

The treatment with crystallyn Penicillin was done to a number of 59 cases (36,3%) and the rejection of the seroreactions has been made after a time waring from 3 to 11 months. A number of 7 cases (4,23%) were treated with Efitard, the rejection of the reactions has been done under the treatment with Moldamin and the rejection of the treatment with Moldamin and the rejection of the reactions has occurred after 3-14 months.

As conclusion, the application of these schemes of treatment brought favorable results in 98% of cases ant the treatment with Moldamin seems to be most useful and convenient.